The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
37
No.
14
April 08, 2011
- CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research
- Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms
- FDA, Genentech Agree On Framework for Avastin Hearing June 28-29
- Nobel Laureate Baruch Blumberg Dies at 85
- Southwest Oncology Group Becomes “SWOG”
TCL
Vol.
37
No.
15
April 15, 2011
- FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression
- Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research
- Congress Cuts $210 Million From NIH Budget For The Remainder of 2011
- American Cancer Society Awards $51.4 million in research grants
TCL
Vol.
37
No.
16
April 22, 2011
- Cooperative Groups Start To Deploy Medidata Rave, Despite Contract Dispute
- Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard
- ASCO Conquer Cancer Foundation Awards $6 Million To Researchers
- Kathy Giusti Named One of The TIME’s 100 Most Influential People
TCL
Vol.
37
No.
17
April 29, 2011
- Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable
- Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent
- Henschke Responds To Questions from The New York Times
- Raymond Weiss Reviews Confidential Report on I-ELCAP
CCL
Vol.
34
No.
4
April 29, 2011
- IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds
- Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting
- Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint
- Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors
- Study Validates “PEM” Scans As Biopsy Guidance Method
- Prostatectomy Lowers Death Risk Compared to Watchful Waiting
- Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk
- Acupuncture Can Relieve Side Effects of Hormone Treatment
- Selumetinib Displays Positive Results, 60% with Stable Disease
- National Health Organizations Warn of Risks in Indoor Tanning
- Clinical Trials Approved By NCI CTEP Last Month
- SWOG Launching New Study Based on Recurrence Test Scores
- Centocor Withdraws Yondelis After FDA Calls for New Study
- FDA Approves New Device For Glioblastoma Multiforme
- EU Gives Marketing Approval For HBV Sequencing Test
- Roche Markets CMV Test in Europe
TCL
Vol.
37
No.
18
May 06, 2011
- Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster”
- I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers
- FDA Approves Afinitor For pNET; No Word On Sutent For Same Use
- The President’s Cancer Panel publishes its annual report